This functional mapping study (n=24) examined brain changes in healthy adults before, during, and up to 3 weeks after taking oral psilocybin (25mg) and methylphenidate (Ritalin), with a follow-up 6+ months later. Psilocybin caused over 3-fold greater acute changes in functional networks than Ritalin, with the most significant disruptions observed in the default mode network (DMN), linked to our sense of self. While a perceptual task reduced these changes, suggesting a way to ground individuals during psychedelic therapy, the acute effects of psilocybin were consistent with distortions of space-time and self. Notably, psilocybin led to a persistent decrease in connectivity between the anterior hippocampus and cortex, especially the DMN, lasting weeks but normalizing after six months, potentially explaining its pro-plasticity and anti-depressant effects.
Abstract of Psilocybin desynchronizes the human brain
“A single dose of psilocybin, a psychedelic that acutely causes distortions of space–time perception and ego dissolution, produces rapid and persistent therapeutic effects in human clinical trials In animal models, psilocybin induces neuroplasticity in cortex and hippocampus. It remains unclear how human brain network changes relate to subjective and lasting effects of psychedelics. Here we tracked individual-specific brain changes with longitudinal precision functional mapping (roughly 18 magnetic resonance imaging visits per participant). Healthy adults were tracked before, during and for 3 weeks after high-dose psilocybin (25 mg) and methylphenidate (40 mg), and brought back for an additional psilocybin dose 6–12 months later. Psilocybin massively disrupted functional connectivity (FC) in cortex and subcortex, acutely causing more than threefold greater change than methylphenidate. These FC changes were driven by brain desynchronization across spatial scales (areal, global), which dissolved network distinctions by reducing correlations within and anticorrelations between networks. Psilocybin-driven FC changes were strongest in the default mode network, which is connected to the anterior hippocampus and is thought to create our sense of space, time and self. Individual differences in FC changes were strongly linked to the subjective psychedelic experience. Performing a perceptual task reduced psilocybin-driven FC changes. Psilocybin caused persistent decrease in FC between the anterior hippocampus and default mode network, lasting for weeks. Persistent reduction of hippocampal-default mode network connectivity may represent a neuroanatomical and mechanistic correlate of the proplasticity and therapeutic effects of psychedelics.”
Authors: Joshua S. Siegel, Subha Subramanian, Demetrius Perry, Benjamin Kay, Evan Gordon, Timothy Laumann, Rick Reneau, Caterina Gratton, Christine Horan, Nicholas Metcalf, Ravi Chacko, Julie Schweiger, Dean Wong, David Bender, Jonah Padawer-Curry, Charles Raison, Marcus Raichle, Eric J. Lenze, Abraham Z Snyder, Nico U. F. Dosenbach & Ginger Nicol
Summary of Psilocybin desynchronizes the human brain
Psychedelic drugs can induce powerful changes in the perception of self, time, and space via the serotonin 2A receptor (5-HT2A receptor) agonism. Acute effects of psilocybin include increased glucose metabolism in the frontal and medial temporal cortex, decreased signal power and functional connectivity, and increased growth of neurons and synapses in vivo and in vitro.
Precision function mapping (PFM) is a method that uses dense repeated rsfMRI to reveal the time course of individual-specific intervention-driven brain connectivity changes. It was applied to study the acute and persistent effects of a single high dose of psilocybin (25mg).
Find this paper
Psilocybin desynchronizes the human brain
https://doi.org/10.1038/s41586-024-07624-5
Open Access | Google Scholar | Backup | 🕊
Cite this paper (APA)
Siegel, J. S., Subramanian, S., Perry, D. A., Kay, B. P., Gordon, E. M., Laumann, T. O., ... & Nicol, G. E. (2024). Psilocybin desynchronizes the human brain. Nature
Study details
Compounds studied
Psilocybin
Topics studied
Healthy Subjects
Neuroscience
Study characteristics
Original
Single-Blind
Within-Subject
Randomized
Participants
24
Humans
Authors
Authors associated with this publication with profiles on Blossom
Charles RaisonCharles "Chuck" L. Raison is an American psychiatrist and professor of psychiatry. Next to his academic affiliation, he is also affiliated with the Usona Institute.
Institutes
Institutes associated with this publication
Washington University School of MedicineLocated in St. Louis Missouri, researchers at the Washington University School of Medicine have conducted a number of studies with psychedelics inlcuding ketamine, psilocybin and nitrous oxide.
Compound Details
The psychedelics given at which dose and how many times
Psilocybin 25 mg | 1xLinked Clinical Trial
Precision Functional Brain Mapping in PsilocybinThis project will employ functional brain imaging to study the mechanism and immediate and long-term effects of psilocybin, a serotonin receptor 2A agonist, on cortical and cortico-subcortical brain networks in healthy adults.